A detailed history of Wolverine Trading, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 55,685 shares of RXRX stock, worth $353,599. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,685
Previous 16,460 238.3%
Holding current value
$353,599
Previous $108,000 248.15%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$5.7 - $8.27 $223,582 - $324,390
39,225 Added 238.3%
55,685 $376,000
Q3 2024

Nov 14, 2024

SELL
$5.92 - $8.6 $25,278 - $36,722
-4,270 Reduced 20.6%
16,460 $108,000
Q2 2024

Aug 14, 2024

BUY
$7.35 - $10.05 $22,005 - $30,089
2,994 Added 16.88%
20,730 $155,000
Q1 2024

May 15, 2024

BUY
$9.13 - $15.52 $161,929 - $275,262
17,736 New
17,736 $176,000

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.15B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.